Prostate Cancer - Results from #25180

Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer : Report of feasibility and acute toxicity - Abstract November 6, 2012

Prostate-specific antigen nadir and time to prostate-specific antigen nadir following maximal androgen blockade independently predict prognosis in patients with metastatic prostate cancer - Abstract November 6, 2012

Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer - Abstract November 6, 2012

Practical issues and pitfalls in staging tumors of the genitourinary tract - Abstract November 6, 2012

Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy - Abstract November 6, 2012

Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer - Abstract November 6, 2012

Competing event risk stratification may improve the design and efficiency of clinical trials: Secondary analysis of SWOG 8794 - Abstract November 6, 2012

Treatment of prostate cancer local recurrence after whole-gland cryosurgery with frameless robotic stereotactic body radiotherapy: Initial experience - Abstract November 6, 2012

Outcome of simple prophylactic procedure of inguinal hernia after radical prostatectomy - Abstract November 5, 2012

Toxicity and outcome of pelvic IMRT for node-positive prostate cancer - Abstract November 5, 2012

Mucin-producing tumors and tumor-like lesions involving the prostate: A comprehensive review - Abstract November 5, 2012

Characterization of germline copy number variation in high-risk African American families with prostate cancer - Abstract November 5, 2012

Diffusion-weighted MRI and PSA correlations in patients with prostate cancer treated with radiation and hormonal therapy - Abstract November 5, 2012

Investigative clinical study on prostate cancer part IX and X: Estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy - Abstract November 5, 2012

Postoperative pelvic hypofractionated accelerated radiotherapy with cytoprotection (HypoARC) for high-risk or recurrent prostate cancer - Abstract November 5, 2012

Prostate cancer in patients with metabolic syndrome is associated with low grade Gleason score when diagnosed on biopsy - Abstract November 5, 2012

Overall survival (OS) benefit with sipuleucel-T by baseline PSA: An exploratory analysis from the phase III IMPACT trial - Abstract November 3, 2012

Urinary incontinence in early experience with robot-assisted laparoscopic prostatectomy-comparison with radical retropubic prostatectomy - Abstract November 2, 2012

Importance of radical prostatectomy for patients older than 70 years - Abstract November 2, 2012

Late complications after radiotherapy for prostate cancer - Abstract November 2, 2012

Page 1260 of 1472